MSN: UC, UC Health launching clinical trial to study effectiveness of COVID-19 vaccine
Vaccine uses a genetic code to produce proteins that may generate protective antibodies
UC and UC Health are hosting a Phase 3 clinical trial to evaluate the effectiveness of a vaccine for COVID-19. UC is one of 90 sites across the United States selected for the study, which will administer the vaccine to volunteer participants and monitor its efficacy in eliciting an immune response that provides protection from COVID-19. The study is led by Carl Fichtenbaum, MD, and Maggie Powers-Fletcher, PhD, both of the UC College of Medicine Division of Infectious Diseases.
Other coverage:
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
Imaging reveals how a tumor-fighting drug triggers cellular breakdown
August 24, 2026
Optics trade publication SPIE highlighted research led by the University of Cincinnati's Jiajie Diao, PhD, published in Biophotonics Discovery that demonstrated how super-resolution microscopy can track how a drug alters several important structures within cancer cells.
Back to School 2026: UC remains a destination campus
August 24, 2026
The University of Cincinnati welcomes its largest first-year class and a record share of first-generation students for fall 2026, reinforced by affordability initiatives, co-op opportunities and new academic offerings across all campuses.
What is electroacoustic music?
August 21, 2026
Professor Mara Helmuth spoke with Cincinnati Spotlight about her upcoming faculty recital on Cincinnati Spotlight.